{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T07:57:37Z","timestamp":1772524657438,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1038\/s41433-025-04230-1","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T08:20:23Z","timestamp":1768206023000},"page":"498-504","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring retinal and choroidal characteristics on multimodal imaging in resolved central serous chorioretinopathy"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0583-2450","authenticated-orcid":false,"given":"Femke M.","family":"van den Tillaart","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer M.","family":"Chang-Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carel B.","family":"Hoyng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roselie M. H.","family":"Diederen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinier O.","family":"Schlingemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camiel J. F.","family":"Boon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elon H. C.","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8037-2978","authenticated-orcid":false,"given":"Suzanne","family":"Yzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"4230_CR1","doi-asserted-by":"publisher","unstructured":"Feenstra HMA, van Dijk EHC, Cheung CMG, Ohno-Matsui K, Lai TYY, Koizumi H, et al. Central serous chorioretinopathy: an evidence-based treatment guideline. Prog Retin Eye Res. 2024:101236. https:\/\/doi.org\/10.1016\/j.preteyeres.2024.101236.","DOI":"10.1016\/j.preteyeres.2024.101236"},{"key":"4230_CR2","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.oret.2023.10.007","volume":"8","author":"LJB Pauleikhoff","year":"2024","unstructured":"Pauleikhoff LJB, Diederen RMH, Chang-Wolf JM, Moll AC, Schlingemann RO, van Dijk EHC, et al. Choroidal vascular changes on ultrawidefield indocyanine green angiography in central serous chorioretinopathy: certain study report 1. Ophthalmol Retin. 2024;8:254\u201363. https:\/\/doi.org\/10.1016\/j.oret.2023.10.007.","journal-title":"Ophthalmol Retin"},{"key":"4230_CR3","doi-asserted-by":"publisher","unstructured":"Cheung CMG, Dansingani KK, Koizumi H, Lai TYY, Sivaprasad S, Boon CJF, et al. Pachychoroid disease: review and update. Eye (Lond). 2024. https:\/\/doi.org\/10.1038\/s41433-024-03253-4.","DOI":"10.1038\/s41433-024-03253-4"},{"key":"4230_CR4","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1097\/iae.0000000000001443","volume":"37","author":"A Daruich","year":"2017","unstructured":"Daruich A, Matet A, Marchionno L, De Azevedo JD, Ambresin A, Mantel I, et al. Acute central serous chorioretinopathy: factors influencing episode duration. Retina. 2017;37:1905\u201315. https:\/\/doi.org\/10.1097\/iae.0000000000001443.","journal-title":"Retina"},{"key":"4230_CR5","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.preteyeres.2015.05.003","volume":"48","author":"A Daruich","year":"2015","unstructured":"Daruich A, Matet A, Dirani A, Bousquet E, Zhao M, Farman N, et al. Central serous chorioretinopathy: recent findings and new physiopathology hypothesis. Prog Retin Eye Res. 2015;48:82\u2013118. https:\/\/doi.org\/10.1016\/j.preteyeres.2015.05.003.","journal-title":"Prog Retin Eye Res"},{"key":"4230_CR6","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1136\/bjophthalmol-2018-312435","volume":"103","author":"SR Singh","year":"2019","unstructured":"Singh SR, Matet A, van Dijk EHC, Daruich A, Fauser S, Yzer S, et al. Discrepancy in current central serous chorioretinopathy classification. Br J Ophthalmol. 2019;103:737\u201342. https:\/\/doi.org\/10.1136\/bjophthalmol-2018-312435.","journal-title":"Br J Ophthalmol"},{"key":"4230_CR7","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1016\/j.ophtha.2018.04.021","volume":"125","author":"EHC van Dijk","year":"2018","unstructured":"van Dijk EHC, Fauser S, Breukink MB, Blanco-Garavito R, Groenewoud JMM, Keunen JEE, et al. Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: the place trial. Ophthalmology. 2018;125:1547\u201355. https:\/\/doi.org\/10.1016\/j.ophtha.2018.04.021.","journal-title":"Ophthalmology"},{"key":"4230_CR8","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ajo.2021.06.020","volume":"233","author":"TJ van Rijssen","year":"2022","unstructured":"van Rijssen TJ, van Dijk EHC, Tsonaka R, Feenstra HMA, Dijkman G, Peters PJH, et al. Half-dose photodynamic therapy versus eplerenone in chronic central serous chorioretinopathy (spectra): a randomized controlled trial. Am J Ophthalmol. 2022;233:101\u201310. https:\/\/doi.org\/10.1016\/j.ajo.2021.06.020.","journal-title":"Am J Ophthalmol"},{"key":"4230_CR9","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ophtha.2007.02.032","volume":"115","author":"AS Kitzmann","year":"2008","unstructured":"Kitzmann AS, Pulido JS, Diehl NN, Hodge DO, Burke JP. The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002. Ophthalmology. 2008;115:169\u201373. https:\/\/doi.org\/10.1016\/j.ophtha.2007.02.032.","journal-title":"Ophthalmology"},{"key":"4230_CR10","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1159\/000324599","volume":"46","author":"AC Fok","year":"2011","unstructured":"Fok AC, Chan PP, Lam DS, Lai TY. Risk factors for recurrence of serous macular detachment in untreated patients with central serous chorioretinopathy. Ophthalmic Res. 2011;46:160\u20133. https:\/\/doi.org\/10.1159\/000324599.","journal-title":"Ophthalmic Res"},{"key":"4230_CR11","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.2147\/opth.S242926","volume":"14","author":"D Mohabati","year":"2020","unstructured":"Mohabati D, Boon CJF, Yzer S. Risk of recurrence and transition to chronic disease in acute central serous chorioretinopathy. Clin Ophthalmol. 2020;14:1165\u201375. https:\/\/doi.org\/10.2147\/opth.S242926.","journal-title":"Clin Ophthalmol"},{"key":"4230_CR12","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/eye.2016.79","volume":"30","author":"A Ozkaya","year":"2016","unstructured":"Ozkaya A, Alkin Z, Ozveren M, Yazici AT, Taskapili M. The time of resolution and the rate of recurrence in acute central serous chorioretinopathy following spontaneous resolution and low-fluence photodynamic therapy: a case-control study. Eye (Lond). 2016;30:1005\u201310. https:\/\/doi.org\/10.1038\/eye.2016.79.","journal-title":"Eye (Lond)"},{"key":"4230_CR13","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/aos.14775","volume":"99","author":"TJ van Rijssen","year":"2021","unstructured":"van Rijssen TJ, van Dijk EHC, Scholz P, Breukink MB, Dijkman G, Peters PJH, et al. Long-term follow-up of chronic central serous chorioretinopathy after successful treatment with photodynamic therapy or micropulse laser. Acta Ophthalmol. 2021;99:805\u201311. https:\/\/doi.org\/10.1111\/aos.14775.","journal-title":"Acta Ophthalmol"},{"key":"4230_CR14","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/s0161-6420(89)32810-7","volume":"96","author":"R Levine","year":"1989","unstructured":"Levine R, Brucker AJ, Robinson F. Long-term follow-up of idiopathic central serous chorioretinopathy by fluorescein angiography. Ophthalmology. 1989;96:854\u20139. https:\/\/doi.org\/10.1016\/s0161-6420(89)32810-7.","journal-title":"Ophthalmology"},{"key":"4230_CR15","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1016\/j.ophtha.2010.01.023","volume":"117","author":"I Maruko","year":"2010","unstructured":"Maruko I, Iida T, Sugano Y, Ojima A, Ogasawara M, Spaide RF. Subfoveal choroidal thickness after treatment of central serous chorioretinopathy. Ophthalmology. 2010;117:1792\u20139. https:\/\/doi.org\/10.1016\/j.ophtha.2010.01.023.","journal-title":"Ophthalmology"},{"key":"4230_CR16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/IAE.0b013e3181e378f2","volume":"31","author":"JY Shin","year":"2011","unstructured":"Shin JY, Woo SJ, Yu HG, Park KH. Comparison of efficacy and safety between half-fluence and full-fluence photodynamic therapy for chronic central serous chorioretinopathy. Retina. 2011;31:119\u201326. https:\/\/doi.org\/10.1097\/IAE.0b013e3181e378f2.","journal-title":"Retina"},{"key":"4230_CR17","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1097\/iae.0000000000003686","volume":"43","author":"HMA Feenstra","year":"2023","unstructured":"Feenstra HMA, Diederen RMH, Lamme M, Tsonaka R, Fauser S, Yzer S, et al. Increasing evidence for the safety of fovea-involving half-dose photodynamic therapy for chronic central serous chorioretinopathy. Retina. 2023;43:379\u201388. https:\/\/doi.org\/10.1097\/iae.0000000000003686.","journal-title":"Retina"},{"key":"4230_CR18","doi-asserted-by":"publisher","unstructured":"Han KJ, Kim HJ, Woo JM, Min JK Comparison of retinal layer thickness and capillary vessel density in the patients with spontaneously resolved acute central serous chorioretinopathy. J Clin Med. 2020;10. https:\/\/doi.org\/10.3390\/jcm10010045.","DOI":"10.3390\/jcm10010045"},{"key":"4230_CR19","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1097\/iae.0000000000003157","volume":"41","author":"TJ van Rijssen","year":"2021","unstructured":"van Rijssen TJ, Hahn LC, van Dijk EHC, Tsonaka R, Scholz P, Breukink MB, et al. Response of choroidal abnormalities to photodynamic therapy versus micropulse laser in chronic central serous chorioretinopathy: place trial report no. 4. Retina. 2021;41:2122\u201331. https:\/\/doi.org\/10.1097\/iae.0000000000003157.","journal-title":"Retina"},{"key":"4230_CR20","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.oret.2020.07.026","volume":"4","author":"J Chhablani","year":"2020","unstructured":"Chhablani J, Cohen FB. Multimodal imaging-based central serous chorioretinopathy classification. Ophthalmol Retin. 2020;4:1043\u20136. https:\/\/doi.org\/10.1016\/j.oret.2020.07.026.","journal-title":"Ophthalmol Retin"},{"key":"4230_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-015-0939-z","volume":"16","author":"MB Breukink","year":"2015","unstructured":"Breukink MB, Downes SM, Querques G, van Dijk EHC, den Hollander AI, Blanco-Garavito R, et al. Comparing half-dose photodynamic therapy with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial): study protocol for a randomized controlled trial. Trials. 2015;16:419. https:\/\/doi.org\/10.1186\/s13063-015-0939-z.","journal-title":"Trials"},{"key":"4230_CR22","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.oret.2022.04.023","volume":"6","author":"HMA Feenstra","year":"2022","unstructured":"Feenstra HMA, Hensman J, Gkika T, Lipkova V, Hoyng CB, Diederen RMH, et al. Spontaneous resolution of chronic central serous chorioretinopathy: \u201cFuji sign. Ophthalmol Retin. 2022;6:861\u20133. https:\/\/doi.org\/10.1016\/j.oret.2022.04.023.","journal-title":"Ophthalmol Retin"},{"key":"4230_CR23","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1097\/IAE.0b013e3181d87e04","volume":"30","author":"NZ Gregori","year":"2010","unstructured":"Gregori NZ, Feuer W, Rosenfeld PJ. Novel method for analyzing snellen visual acuity measurements. Retina. 2010;30:1046\u201350. https:\/\/doi.org\/10.1097\/IAE.0b013e3181d87e04.","journal-title":"Retina"},{"key":"4230_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2021.100973","volume":"86","author":"RF Spaide","year":"2022","unstructured":"Spaide RF, Gemmy Cheung CM, Matsumoto H, Kishi S, Boon CJF, van Dijk EHC, et al. Venous overload choroidopathy: a hypothetical framework for central serous chorioretinopathy and allied disorders. Prog Retin Eye Res. 2022;86:100973. https:\/\/doi.org\/10.1016\/j.preteyeres.2021.100973.","journal-title":"Prog Retin Eye Res"},{"key":"4230_CR25","doi-asserted-by":"publisher","unstructured":"Pauleikhoff LJB, Chang-Wolf JM, Diederen RMH, Moll AC, Schlingemann RO, van Dijk EHC, et al. Ultra-widefield indocyanine green angiographic changes after photodynamic therapy in central serous chorioretinopathy. certain study report 3. Retina. 2025. https:\/\/doi.org\/10.1097\/iae.0000000000004414.","DOI":"10.1097\/iae.0000000000004414"},{"key":"4230_CR26","doi-asserted-by":"publisher","first-page":"760","DOI":"10.3928\/23258160-20191119-03","volume":"50","author":"YJ Park","year":"2019","unstructured":"Park YJ, Kim YK, Park KH, Woo SJ. Long-term efficacy and safety of photodynamic therapy in patients with chronic central serous chorioretinopathy. Ophthalmic Surg Lasers Imaging Retin. 2019;50:760\u201370. https:\/\/doi.org\/10.3928\/23258160-20191119-03.","journal-title":"Ophthalmic Surg Lasers Imaging Retin"},{"key":"4230_CR27","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1097\/iae.0000000000003807","volume":"43","author":"LJB Pauleikhoff","year":"2023","unstructured":"Pauleikhoff LJB, Diederen RMH, Feenstra HMA, Schlingemann RO, van Dijk EHC, Boon CJF. Single-session bilateral reduced-settings photodynamic therapy for bilateral chronic central serous chorioretinopathy. Retina. 2023;43:1356\u201363. https:\/\/doi.org\/10.1097\/iae.0000000000003807.","journal-title":"Retina"},{"key":"4230_CR28","doi-asserted-by":"publisher","first-page":"e0202549","DOI":"10.1371\/journal.pone.0202549","volume":"13","author":"TJ van Rijssen","year":"2018","unstructured":"van Rijssen TJ, Mohabati D, Dijkman G, Theelen T, de Jong EK, van Dijk EHC, et al. Correlation between redefined optical coherence tomography parameters and best-corrected visual acuity in non-resolving central serous chorioretinopathy treated with half-dose photodynamic therapy. PLoS One. 2018;13:e0202549 https:\/\/doi.org\/10.1371\/journal.pone.0202549.","journal-title":"PLoS One"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04230-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04230-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04230-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T07:12:56Z","timestamp":1772521976000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04230-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["4230"],"URL":"https:\/\/doi.org\/10.1038\/s41433-025-04230-1","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"18 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"CJFB is a member of the Eye editorial board.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}